<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Introduction </plain></SENT>
<SENT sid="1" pm="."><plain>The objective of this study was to evaluate Ki-67 antigen expression in patients with <z:hpo ids='HP_0100580'>Barrett's esophagus</z:hpo> and esophageal <z:mp ids='MP_0009308'>adenocarcinoma</z:mp> and to assess its correlation with the <z:mpath ids='MPATH_160'>metaplasia</z:mpath>-esophageal <z:mp ids='MP_0009308'>adenocarcinoma</z:mp> progression </plain></SENT>
<SENT sid="2" pm="."><plain>Methods </plain></SENT>
<SENT sid="3" pm="."><plain>Using immunohistochemistry we evaluated the Ki-67 index in patients with <z:hpo ids='HP_0100580'>Barrett's esophagus</z:hpo>, esophageal <z:mp ids='MP_0009308'>adenocarcinoma</z:mp>, and controls </plain></SENT>
<SENT sid="4" pm="."><plain>We included patients with endoscopically visible columnar mucosa of the distal esophagus (whose biopsies revealed specialized intestinal-type <z:mpath ids='MPATH_160'>metaplasia</z:mpath>), patients with esophageal and esophagogastric <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumors</z:e> types I and II, and patients with histologically <z:mpath ids='MPATH_458'>normal</z:mpath> gastric mucosa (control) </plain></SENT>
<SENT sid="5" pm="."><plain>Results </plain></SENT>
<SENT sid="6" pm="."><plain>In the 57 patients studied there were no statistically significant differences between the groups with respect to age or race </plain></SENT>
<SENT sid="7" pm="."><plain>Patients with <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> were predominantly men </plain></SENT>
<SENT sid="8" pm="."><plain>The Ki-67 index averaged 10 ± 4 % in patients with <z:mpath ids='MPATH_458'>normal</z:mpath> gastric mucosa (n = 17), 21 ± 15 % in patients with <z:hpo ids='HP_0100580'>Barrett's esophagus</z:hpo> (n = 21), and 38 ± 16 % in patients with <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> (n = 19) </plain></SENT>
<SENT sid="9" pm="."><plain>Ki-67 expression was significantly different between <z:hpo ids='HP_0000001'>all</z:hpo> groups (P &lt; 0.05) </plain></SENT>
<SENT sid="10" pm="."><plain>There was a strong linear correlation between Ki-67 expression and the <z:mpath ids='MPATH_160'>metaplasia</z:mpath>-<z:mp ids='MP_0009308'>adenocarcinoma</z:mp> sequence (P &lt; 0.01) </plain></SENT>
<SENT sid="11" pm="."><plain>In patients with <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e>, Ki-67 was not associated with clinical or surgical staging </plain></SENT>
<SENT sid="12" pm="."><plain>Conclusions </plain></SENT>
<SENT sid="13" pm="."><plain>Ki-67 antigen has increased expression along the <z:mpath ids='MPATH_160'>metaplasia</z:mpath>-<z:mp ids='MP_0009308'>adenocarcinoma</z:mp> sequence </plain></SENT>
<SENT sid="14" pm="."><plain>There is a strong linear correlation between Ki-67 proliferative activity and Barrett's <z:e sem="disease" ids="C0596263" disease_type="Neoplastic Process" abbrv="">carcinogenesis</z:e> </plain></SENT>
</text></document>